Table 2.
Treatment-related adverse events.
| TACE-RFA (n = 209) | TACE (n = 195) | P value | |
|---|---|---|---|
| Grade 1-2/3-4 | Grade 1-2/3-4 | ||
| Pain | 120/4 | 103/2 | 0.690 |
| Fever (temperature >38.5°C) | 76/1 | 59/1 | 0.999 |
| Vomiting | 86/10 | 70/7 | 0.804 |
| Ascites | 6/1 | 6/1 | 0.999 |
| Pleural effusion | 12/1 | 15/2 | 0.999 |
| Bile duct stenosis | 2/0 | 1/0 | 0.999 |
| Gastric hemorrhage | 2/0 | 1/1 | 0.999 |
| Abdominal infection | 0/1 | 0/1 | 0.999 |
| Small intestinal obstruction | 0/1 | 0/0 | 0.999 |
Data values represent the number of patients. TACE: transarterial chemoembolization; RFA: radiofrequency ablation.